A2DMQY Cronos Group Inc

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding.

Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of 92.3% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows:

Name of DirectorNumber of Shares Voted ForPercentage of Shares Voted ForNumber of Shares Withheld from VotingPercentage of Shares Withheld from Voting
Michael Gorenstein206,219,87592.38%17,012,4437.62%
Jason Adler215,665,94696.61%7,566,3723.39%
Murray Garnick215,548,31296.56%7,684,0063.44%
Kamran Khan216,349,69496.92%6,882,6243.08%
Dominik Meier216,404,34796.94%6,827,9713.06%
Elizabeth Seegar211,177,23294.60%12,055,0865.40%
James Rudyk215,956,20396.74%7,276,1153.26%



Shareholders also approved an advisory (non-binding) resolution on the compensation of the Company’s named executive officers, with 94.13% of votes cast in favor of such resolution, and approved the appointment of Davidson & Company LLP as the Company’s independent auditor for fiscal year 2025 and authorized the Board of Directors of the Company to fix the independent auditor's remuneration.

For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR+ profile at and the Company’s Form 8-K filed on EDGAR at /edgar.

About Cronos

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

For further information, please contact:

Harrison Aaron

Investor Relations

Tel: (416) 504-0004





EN
23/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Sharehol...

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was...

 PRESS RELEASE

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Co...

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST. A live webcast will be available on the Investors section of the Company’s website at . About Cronos Group Inc.Cronos is an innovative global cannabinoid company...

 PRESS RELEASE

Cronos Group Reports 2025 First Quarter Results

Cronos Group Reports 2025 First Quarter Results Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Industry-leading balance sheet with $838 million in total cash and cash equivalents and short-term investments TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 first quarter business results. "2025 is shaping up to be a transformative yea...

 PRESS RELEASE

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2025 Annual Meeting online regardless of their geographic location, including a chance to ask questions and vote. Th...

 PRESS RELEASE

Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call ...

Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025 TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage participants ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch